Upstart Holdings, Inc. shares of the consumer lending platform gained 32% after its first-quarter guidance was stronger than expected. Upstart expects revenue of $200 million for the current quarter, more than the $193.8 million that analysts had penciled in, according to LSEG. Upstart’s fourth-quarter earnings and revenue also beat analysts’ expectations.
SUPER MICRO COMPUTER INC rose 12% after the artificial-intelligence server maker issued strong guidance for fiscal 2026. CEO Charles Liang, in a business update Tuesday, said the company saw fiscal 2025 revenue "in the range of $23.5 billion to $25 billion, paving the way for $40 billion revenue in FY26." The new revenue range for fiscal 2025 was lower than prior guidance for $26 billion to $30 billion, but the $40 billion revenue estimate for fiscal 2026 was well above the current consensus of $29.2 billion. Super Micro also said it expects to be able to file its 10-K with the Securities and Exchange Commission for the year through June 30, and the 10-Q report for the quarter ended in September, by Feb. 25.
CVS Health jumped 15% after the healthcare company posted fourth-quarter earnings that were better than expectations and said it anticipates adjusted earnings in 2025 of between $5.75 and $6 a share, up from $5.42 in 2024, and roughly in line with analysts' consensus.
Gilead Sciences reported fourth-quarter adjusted earnings of $1.90 a share, topping the consensus estimate of $1.74, and it issued guidance for fiscal 2025 that was better than analysts's expectations. The stock was up 8%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.